Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74076 - 74100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	NPAS3	64067	downregulated	Silver results in decreased expression of NPAS3 mRNA	14q13.1	A24216
Silver	Approved Investigational	NQO1	1728	upregulated	Silver results in increased expression of NQO1 mRNA	16q22.1	A24226
Silver	Approved Investigational	OLIG1	116448	downregulated	Silver results in decreased expression of OLIG1 mRNA	21q22.11	A24216
Silver	Approved Investigational	OTX2	5015	downregulated	Silver results in decreased expression of OTX2 mRNA	14q22.3	A24216
Silver	Approved Investigational	PCK2	5106	upregulated	Silver analog results in increased expression of PCK2 mRNA	14q11.2-q12	A24215
Silver	Approved Investigational	PDE1A	5136	downregulated	Silver results in decreased expression of PDE1A mRNA	2q32.1	A24216
Silver	Approved Investigational	PHGDH	26227	upregulated	Silver results in increased expression of PHGDH mRNA	1p12	A24216
Silver	Approved Investigational	PHLDB2	90102	downregulated	Silver results in decreased expression of PHLDB2 mRNA	3q13.2	A24216
Silver	Approved Investigational	PIK3R3	8503	downregulated	Silver results in decreased expression of PIK3R3 mRNA	1p34.1	A24216
Silver	Approved Investigational	PMAIP1	5366	upregulated	Silver analog results in increased expression of PMAIP1 mRNA	18q21.32	A24221
Silver	Approved Investigational	POLR3H	171568	downregulated	Silver results in decreased expression of POLR3H mRNA	22q13.2	A24216
Silver	Approved Investigational	POU3F2	5454	downregulated	Silver results in decreased expression of POU3F2 mRNA	6q16.1	A24216
Silver	Approved Investigational	PPP1R3C	5507	upregulated	Silver results in increased expression of PPP1R3C mRNA	10q23.32	A24216
Silver	Approved Investigational	PRKAG2	51422	upregulated	Silver results in increased expression of PRKAG2 mRNA	7q36.1	A24216
Silver	Approved Investigational	PRKCZ	5590	downregulated	Silver results in decreased expression of PRKCZ mRNA	1p36.33	A24219
Silver	Approved Investigational	PRNP	5621	upregulated	Silver results in increased expression of PRNP mRNA	20p13	A24216
Silver	Approved Investigational	RAB3IP	117177	downregulated	Silver results in decreased expression of RAB3IP mRNA	12q15	A24216
Silver	Approved Investigational	RAB5B	5869	downregulated	Silver results in decreased expression of RAB5B mRNA	12q13	A24216
Silver	Approved Investigational	RASD1	51655	upregulated	Silver results in increased expression of RASD1 mRNA	17p11.2	A24216
Silver	Approved Investigational	RCAN1	1827	upregulated	Silver results in increased expression of RCAN1 mRNA	21q22.12	A24216
Silver	Approved Investigational	RFX4	5992	downregulated	Silver results in decreased expression of RFX4 mRNA	12q23.3	A24216
Silver	Approved Investigational	RIPK1	8737	downregulated	Silver analog results in decreased expression of RIPK1 mRNA	6p25.2	A24225
Silver	Approved Investigational	RNF103	7844	upregulated	Silver results in increased expression of RNF103 mRNA	2p11.2	A24216
Silver	Approved Investigational	RPS6KA3	6197	upregulated	Silver results in increased expression of RPS6KA3 mRNA	Xp22.12	A24216
Silver	Approved Investigational	RRAS2	22800	upregulated	Silver results in increased expression of RRAS2 mRNA	11p15.2	A24216

Displaying entries 74076 - 74100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability